KIM MORALES: Open Payments
NPI 1528153814 · WALL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 42 payments from 14 companies in 2025. Trend: 2023 $360 · 2024 $860 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $241 |
| Janssen Biotech, Inc. | 8 | $207 |
| Novartis Pharmaceuticals Corporation | 6 | $109 |
| Incyte Corporation | 5 | $79 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
| Tactile Systems Technology Inc | 1 | $32 |
| Botanix SB Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| ConvaTec Inc. | 1 | $16 |
Products named: TREMFYA, RINVOQ, COSENTYX, OPZELURA, SKYRIZI, NEMLUVIO, Flexitouch Plus, LIBTAYO.
Industry payments across NJ — which companies pay providers there.
